720 related articles for article (PubMed ID: 21916843)
1. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
2. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
3. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
4. The story of Rett syndrome: from clinic to neurobiology.
Chahrour M; Zoghbi HY
Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
[TBL] [Abstract][Full Text] [Related]
5. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
6. Reversibility of functional deficits in experimental models of Rett syndrome.
Cobb S; Guy J; Bird A
Biochem Soc Trans; 2010 Apr; 38(2):498-506. PubMed ID: 20298210
[TBL] [Abstract][Full Text] [Related]
7. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
8. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
[TBL] [Abstract][Full Text] [Related]
9. Rett syndrome: from the gene to the disease.
Matijevic T; Knezevic J; Slavica M; Pavelic J
Eur Neurol; 2009; 61(1):3-10. PubMed ID: 18948693
[TBL] [Abstract][Full Text] [Related]
10. Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches.
Ricceri L; De Filippis B; Laviola G
Behav Pharmacol; 2008 Sep; 19(5-6):501-17. PubMed ID: 18690105
[TBL] [Abstract][Full Text] [Related]
11. MeCP2 involvement in the regulation of neuronal alpha-tubulin production.
Abuhatzira L; Shemer R; Razin A
Hum Mol Genet; 2009 Apr; 18(8):1415-23. PubMed ID: 19174478
[TBL] [Abstract][Full Text] [Related]
12. A segment of the Mecp2 promoter is sufficient to drive expression in neurons.
Adachi M; Keefer EW; Jones FS
Hum Mol Genet; 2005 Dec; 14(23):3709-22. PubMed ID: 16251199
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of disease: neurogenetics of MeCP2 deficiency.
Francke U
Nat Clin Pract Neurol; 2006 Apr; 2(4):212-21. PubMed ID: 16932552
[TBL] [Abstract][Full Text] [Related]
14. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
Tao J; Wu H; Sun YE
Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
[TBL] [Abstract][Full Text] [Related]
15. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
[TBL] [Abstract][Full Text] [Related]
16. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
[TBL] [Abstract][Full Text] [Related]
17. Rett syndrome: of girls and mice--lessons for regression in autism.
Glaze DG
Ment Retard Dev Disabil Res Rev; 2004; 10(2):154-8. PubMed ID: 15362175
[TBL] [Abstract][Full Text] [Related]
18. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
19. Autonomic dysfunction with mutations in the gene that encodes methyl-CpG-binding protein 2: insights into Rett syndrome.
Lioy DT; Wu WW; Bissonnette JM
Auton Neurosci; 2011 Apr; 161(1-2):55-62. PubMed ID: 21316312
[TBL] [Abstract][Full Text] [Related]
20. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS
Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]